Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Contemp Clin Trials. 2023 Sep 18;133:107339. doi: 10.1016/j.cct.2023.107339

Table 2.

Outcome collection timeline

Measure Time point
BL 20-wk 6-mo
Informed Consent X
Screening Questionnaires: X
 Alcohol Use Disorders Identification Test (AUDIT)
 Drug Abuse Screen Test (DAST-10)
Pregnancy test (urine), if applicable X
2-minute step in place test X X X
Resting HR, oxygen saturation and blood pressure X X X
Weight X X X
Spirometry X X X
Muscle Strength X X X
Neurosensory integrity X X X
Physical activity and HR/HR variability X X X
Questionnaire: X X X
 Physical activity Readiness Questionnaire (PAR-Q)
Questionnaires: X X X
 Physical Activity Related Health History
 Patient Health Questionnaire (PHQ-8)
 Generalized Anxiety Disorder (GAD-7)
 PROMIS Ability to Participate 8a (SF v2.0)
 Work Productivity and Activity Impairment Questionnaire (WPAI)
 Work and Social Adjustment Scale (WSAS)
 Medical Outcomes Survey Short Form (SF-36)
 Childhood Cancer Survivor Study Neurocognitive
 Questionnaire – Revised (CCSS-NCQ)
Questionnaire (Acceptability Measures): X X
 Service User Technology Acceptability Questionnaire (SUTAQ)
 System Usability Scale (SUS)
OPTIONAL: Biomarkers (saliva), if applicable X X X

Abbreviations: BL, baseline; HR, heart rate; mo, month; wk, week